- Filed
- Mar 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 12, 2025 | 24.13M sh |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 25.07M sh |
| Capex | FY 2024 · Dec 31, 2023 | $7.71M |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$13.54M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $748K |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $37.33M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $70.01M |
| Current Assets restated | FY 2024 · Dec 31, 2023 | $115.68M |
| Total Assets | FY 2024 · Dec 31, 2023 | $506.74M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | $2.17 |
| Eps Basic | FY 2024 · Dec 31, 2023 | $2.23 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $24.28M |
| Net Income | FY 2024 · Dec 31, 2023 | $54.46M |
| Operating Income | FY 2024 · Dec 31, 2023 | $64.59M |
| Cost Of Revenue | FY 2024 · Dec 31, 2023 | $99.69M |
| Revenue | FY 2024 · Dec 31, 2023 | $145.1M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $382.1M |